3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Cannabinol: new trials by email Literature Review of Cannabinol trials Research Report on Cannabinol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabinol Use in Patients With Insomnia Disorder 30 mg Cannabinol (CBN), 300 mg Cannabinol (CBN), Placebo - Insomnia Disorder | Phase 1 / Phase 2 | Completed | Woolcock Institute of Medical Research | 20 | 2022-08-24 | 2024-02-06 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality CBN and CBD - Healthy Adults | Phase 1 / Phase 2 | Completed | Canopy Growth Corporation | 301 | 2022-05-16 | 2023-05-03 |
| INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa INM-755 (cannabinol) cream, Vehicle Cream - Epidermolysis Bullosa Simplex, Epidermolysis Bullosa, Junctional | Phase 2 | Completed | InMed Pharmaceuticals Inc. | 19 | 2021-12-28 | 2023-07-03 |
Epidermolysis Bullosa Dystrophica (1) · Epidermolysis Bullosa Simplex (1) · Epidermolysis Bullosa, Junctional (1) · Poikiloderma of Kindler (1) · Sleep Initiation and Maintenance Disorders (1)
Canopy Growth Corporation (1) · InMed Pharmaceuticals Inc. (1) · Woolcock Institute of Medical Research (1)
Australia (1) · France (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · United States (1)
Alexandra DJ Mancini, MSc (1) · Brendon Yee, MBChB, FRACP, FCCP, PhD (1) · Camilla Hoyos, MPH, PhD (1) · Matthew T Feldner, PhD (1)